Home  |  Journals  |  Conferences |   Membership  |   FAQ's Join  |  Contact  |   Sitemap  |             
OMICS Group Inc

International Journal of Clinical & Medical Images

ISSN: 2376-0249
Open Access
 
 
  • Images in Haematology

    RBC and WBCs

  • Images on Cardiac Innovation

    instrumentation & innovation

  • Cardio Imaging

    Advanced Techniques in Cardiology

  • Images in Dentistry

    Dental surgery & education

  • Images in Gynaecology

    Advancement in Obstetrics & Gynaecology

  • Images in Ophthalmology

    Optic vision & cure

  • Medical diagnostic methods

    Clinical & medical assessments

  • Fluorescent Imaging

    Clinical & Medical imaging

  • Images in abdomen

    Current research

  • Images in Immunology

    Procurement & advanced technical images

  • Images in Spine

    Recent research

  • Images in Cardiology

    A heart of living..

 

Junjie Li

Junjie Li

Junjie LI
Odyssey Fellow
Department of Cancer Systems Imaging
University of Texas- MD Anderson Cancer Center

Biography

Dr. Junjie LI is currently working as an Odyssey Fellow with the support of the H-E-B Award for Scientific Achievement at Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center. He has elaborated an alternative and general anticancer approach namely small molecule sequential dual-targeting theragnostic strategy (SMSDTTS) with series of publications during his PhD training at department of Imaging & Pathology, KU Leuven, Belgium. His research interests include diagnostic imaging (CT, MRI, PET, SPECT, X-ray, Ultrasound, etc.), animal models (Orthotopic and metastatic tumor models, reprefused liver/ myocardial infarction models, micro-angiography, etc.), targeting drug delivery, and targeted cancer nanotherapy, etc.. Pursuing more effective, safer cancer theranostic approaches that are minimally-invasive and cost effective are his long-term goals as a proactive researcher. 

Research Interest

 Animal models, Medical imaging, Cancer theranostics, Targeting drug delivery, Targeted cancer nanotherapy.

 
 
© 2008-2013 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version